XELOX+Bevacizumab Followed by Capecitabine+Bevacizumab+Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma
Clinical trial NCT00557713 · UNKNOWN
Trial details
- NCT number
- NCT00557713
- Sponsor
- Associacio catalana per a la recerca oncologica i les seves implicacions sanitaries i socials
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.